Parulekar W, Di Primio G, Matzinger F, Dennie C, Bociek G
National Cancer Institute of Canada Clinical Trials Group, Queen's University, Kingston ON.
Chest. 2001 Jul;120(1):19-25. doi: 10.1378/chest.120.1.19.
To evaluate the efficacy of small-bore (12 French vanSonnenberg) catheters compared with standard large-bore chest tubes in the drainage and sclerotherapy of malignant pleural effusions.
Retrospective review.
An academic tertiary care hospital.
Adult patients with documented neoplasms and malignant pleural effusions, treated between 1986 and 1995.
All patients included in the study underwent drainage of malignant pleural effusions either by large-bore chest tube or by ultrasound-guided small-bore catheter. After drainage, pleurodesis was performed.
Outcome as defined by recurrence of effusion was determined by blinded examination of all postpleurodesis chest radiographs. We identified 58 cases of malignant pleural effusion in which small-bore catheters were used and 44 in which large-bore chest tubes were used. The majority of patients had breast (n = 56, 55%) or lung cancer (n = 29, 28%). The median age was 65 years. Fifty-nine patients were actively being treated with chemotherapy at the time of pleurodesis. The following sclerosing agents were used: talc, 27 (26%); tetracycline, 72 (70%); bleomycin, 2 (2%); and interferon, 1 (1%). Actuarial probabilities of recurrence at 6 weeks and 4 months were 45% and 53% for the small tubes vs 45% and 51% for the large tubes. Univariate and multivariate analyses failed to demonstrate that tube size had any influence on the rate of recurrence.
We were unable to detect any major differences in outcomes with the use of either size of chest tube. Our study suggests that small-bore catheters may be effective in the treatment of malignant pleural effusions and deserve further evaluation in prospectively designed trials.
评估小口径(12法式范松嫩贝格)导管与标准大口径胸管在恶性胸腔积液引流及硬化治疗中的疗效。
回顾性研究。
一家学术性三级护理医院。
1986年至1995年间接受治疗的有记录的肿瘤及恶性胸腔积液成年患者。
纳入研究的所有患者通过大口径胸管或超声引导下的小口径导管进行恶性胸腔积液引流。引流后进行胸膜固定术。
通过对所有胸膜固定术后胸部X光片进行盲法检查来确定积液复发所定义的结果。我们确定了58例使用小口径导管的恶性胸腔积液病例和44例使用大口径胸管的病例。大多数患者患有乳腺癌(n = 56,55%)或肺癌(n = 29,28%)。中位年龄为65岁。59例患者在胸膜固定术时正在接受化疗。使用了以下硬化剂:滑石粉,27例(26%);四环素,72例(70%);博来霉素,2例(2%);干扰素,1例(1%)。小口径导管在6周和4个月时的复发精算概率分别为45%和53%,大口径导管分别为45%和51%。单因素和多因素分析均未显示导管尺寸对复发率有任何影响。
我们未能检测到使用任何一种尺寸胸管的结果有任何重大差异。我们的研究表明,小口径导管可能对恶性胸腔积液治疗有效,值得在前瞻性设计试验中进一步评估。